Home » General World News » A competitor is emerging to challenge the marijuana retail chain dominating the industry, and it just closed a $640 million acquisition

A competitor is emerging to challenge the marijuana retail chain dominating the industry, and it just closed a $640 million acquisition





marijuana

  • iAnthus, a publicly-traded firm that operates marijuana dispensaries in a number of US states, acquired Toronto-based MPX Bioceutical in a $640 million stock transaction.
  • The acquisition nearly doubles the firm’s footprint as cannabis retailers compete for scale in the burgeoning sector.
  • Earlier in October, MedMen, another cannabis retailer, scooped up PharmaCann in a $682 million acquisition.
  • We’re more like frenemies than enemies,” iAnthus CEO Hadley Ford told Business Insider in an interview.

IAnthus, a publicly-traded firm that operates cannabis retail facilities in the US and Canada, acquired MPX Bioceutical, a Toronto-based cannabis company, in a $640 million stock transaction.

It’s the first public-to-public read more >>>

Source:: BusinessInsider.Com

Comments are closed.